AURA
Price
$5.44
Change
-$0.27 (-4.73%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
273.23M
34 days until earnings call
ORIC
Price
$4.86
Change
-$0.40 (-7.60%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
372.54M
38 days until earnings call
Ad is loading...

AURA vs ORIC

Header iconAURA vs ORIC Comparison
Open Charts AURA vs ORICBanner chart's image
Aura Biosciences
Price$5.44
Change-$0.27 (-4.73%)
Volume$14.12K
Capitalization273.23M
Oric Pharmaceuticals
Price$4.86
Change-$0.40 (-7.60%)
Volume$17.39K
Capitalization372.54M
AURA vs ORIC Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. ORIC commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and ORIC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (AURA: $5.71 vs. ORIC: $5.26)
Brand notoriety: AURA and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 145% vs. ORIC: 92%
Market capitalization -- AURA: $273.23M vs. ORIC: $372.54M
AURA [@Biotechnology] is valued at $273.23M. ORIC’s [@Biotechnology] market capitalization is $372.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileORIC’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • ORIC’s FA Score: 1 green, 4 red.
According to our system of comparison, both AURA and ORIC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while ORIC’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 4 bearish.
  • ORIC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AURA and ORIC are a good buy in the short-term.

Price Growth

AURA (@Biotechnology) experienced а -3.87% price change this week, while ORIC (@Biotechnology) price change was -16.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

AURA is expected to report earnings on May 08, 2025.

ORIC is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC($373M) has a higher market cap than AURA($273M). AURA YTD gains are higher at: -30.535 vs. ORIC (-34.820). AURA has higher annual earnings (EBITDA): -91.84M vs. ORIC (-141.79M). ORIC has more cash in the bank: 256M vs. AURA (174M). ORIC has less debt than AURA: ORIC (3.18M) vs AURA (19.1M). AURA (0) and ORIC (0) have equivalent revenues.
AURAORICAURA / ORIC
Capitalization273M373M73%
EBITDA-91.84M-141.79M65%
Gain YTD-30.535-34.82088%
P/E RatioN/AN/A-
Revenue00-
Total Cash174M256M68%
Total Debt19.1M3.18M600%
TECHNICAL ANALYSIS
Technical Analysis
AURAORIC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Bullish Trend 19 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSBAX60.69N/A
N/A
Nuveen Dividend Growth A
IPEAX5.95N/A
N/A
Voya Large Cap Value Port A
CREAX9.91N/A
N/A
Columbia Real Estate Equity A
PHLQX42.17N/A
N/A
PGIM Jennison Health Sciences R6
HLRRX10.04-0.35
-3.37%
LDR Real Estate Value Opportunity Instl

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with KYMR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
-9.00%
KYMR - ORIC
48%
Loosely correlated
-10.13%
CCCC - ORIC
45%
Loosely correlated
-9.54%
BPMC - ORIC
44%
Loosely correlated
-3.22%
ATXS - ORIC
44%
Loosely correlated
-6.70%
AURA - ORIC
42%
Loosely correlated
-3.87%
More